跳至主要内容
临床试验/NCT04963023
NCT04963023已完成不适用

Specific Biomarker Identification of Different Subgroups of Chronic Obstructive Pulmonary Disease

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2021年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
identification specific blood immunologic marker for COPD

研究概览

简要总结

There are few studies about immunological explorations in COPD. Because of the complications of lung biopsies, analyses are generally made on blood samples instead of lung tissue. No study tried to classify COPD vs Asthma vs ACOS. The investigators wondered if there were differences in biomarkers between these groups. The investigators decided to open a pilot-study among COPD patients followed in Amiens-University Hospital. Each patient will be examined and a blood-test will be performed.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BPCO patients
  • ACOS patients
  • asthmatic patient without BPCO

排除标准

  • infection
  • exacerbation
  • immunosuppressive treatment
  • immunosuppressive disease

结局指标

主要结局

identification specific blood immunologic marker for COPD

时间窗: one hour

COPD biomarkers are blood immunologic markers

次要结局

  • c-reactive protein concentration variation between COPD and asthmatic patients(one hour)
  • Complete blood count (CBC) Variation between COPD and asthmatic patients(one hour)
  • Plasma protein electrophoresis profile Variation between COPD and asthmatic patients(one hour)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验